Definition of Benign Prostatic Hyperplasia (BPH)
BPH is a histologic diagnosis that refers to the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostatic transition zone. 1
Key Conceptual Distinctions
The term "BPH" is frequently misused in clinical practice, and understanding the precise terminology is critical for accurate diagnosis and treatment:
BPH itself is a microscopic pathological finding that describes cellular proliferation in the prostate and does not require treatment—it is not the target of interventions. 1
BPH can lead to benign prostatic enlargement (BPE), which is the macroscopic enlargement of the prostate gland that may be palpable on digital rectal examination or visible on imaging. 1
BPE may cause benign prostatic obstruction (BPO), which is obstruction at the level of the bladder neck due to the enlarged prostate. 1
The clinical syndrome that patients experience is properly termed "lower urinary tract symptoms attributed to BPH" (LUTS/BPH), which encompasses symptoms like hesitancy, weak stream, and nocturia in men for whom an alternative cause is not apparent. 1
Pathophysiology of Symptoms
The urinary symptoms in older men with BPH arise from two distinct mechanisms:
Static component: Direct bladder outlet obstruction from enlarged prostatic tissue physically compressing the urethra. 2, 3
Dynamic component: Increased smooth muscle tone and resistance within the enlarged gland, mediated by alpha-1 adrenergic receptors (approximately 70% are alpha-1A subtype in the prostate). 2, 4, 3
Clinical Presentation
Symptoms are categorized into two groups:
Voiding (obstructive) symptoms: Hesitancy, weak stream, straining, prolonged voiding, intermittency, and sensation of incomplete emptying. 5, 3, 6
Storage (irritative) symptoms: Frequency, urgency, nocturia, urge incontinence, and reduced voiding volumes. 5, 3, 6
Epidemiology
BPH is nearly ubiquitous in aging males, with prevalence reaching 60% by age 60 and 80% by age 80. 2
Moderate-to-severe LUTS affects nearly 50% of men by the eighth decade of life, and approximately 90% of men between ages 45-80 experience some type of LUTS. 1, 2
The condition is rarely life-threatening but significantly impacts quality of life, making symptom severity and patient bother the primary drivers of treatment decisions. 1, 2